Just kind of looks like the beginning of what AT just did.
We could be in ABC correction. Anything below 15.50 and the trouble starts.
shares are trading higher on Monday after B Riley FBR initiated coverage on the company's stock with a Buy rating and announced a $22 price target. In this case, B. Riley FBR appears to be very optimistic about the prospects for Vaxart's oral COVID-19 vaccine candidate. This experimental vaccine was recently selected by the U.S. government's Operation Warp...
Nice bounce from Fib Golden Pocket Potential of a major breakout above $10.00 Using 7ma as stop loss
As illustrated. Sell half at 1R and move STP to entry. Then sell 1/4 at 2R plus move STP to 1R, and so on.
Will the breakthrough come for VXRT? Looking for a small pop with some good news with their current research into a vaccine...the race is on
Vaxart (VXRT, $8) was one of top quarterly gainers, jumping +376.19% to $8 per share. Tickeron A.I.dvisor analyzed 174 stocks in the Pharmaceuticals: Major Industry over the last three months, and discovered that 155 of them (89.09%) charted an Uptrend while 19 of them (10.91%) trended down. Tickeron A.I.dvisor found 135 similar cases when VXRT's price went up 15%...
Bullish flag forming on VXRT. Using fibonacci retracement as support lines. Should end after lunch. This is NOT financial advice.
Looks like a little more downside for VXRT before reversal. Fibonacci golden pocket sitting at mid $6's while also gap fill support. Stock still needs to work off the overbought conditions
$VXRT Pretty obvi that the people who are making money on this are the boys and girls buying up the shares after market close and then dumping on retail during the day. I see why it is attractive, But have to remember is is 1 of 70 - 100 companies that is a covid play. Basically its a lotto ticket at this point and you are buying spec and hype. If you want...
$VXRT off the 20SMS ( on the 4 hour chart) in the after hours trading on Friday!
Price Volatility is mainly due to the Fundamental Analysis. Not a lot to say on Technical Analysis Vaxart Inc. VXRT, +28.43% said Friday its oral COVID-19 vaccine has been selected to take part in a nonhuman primate challenge study funded by the U.S. government’s ‘Operation Warp Speed’ program, that aims to accelerate development of a vaccine. Shares were up more...
Vaxart, Inc. Signs Memorandum of Understanding with Attwill Medical Solutions Sterilflow, LP Enabling Production of A Billion or More COVID-19 Vaccine Doses Per Year Through Large Scale Lyophilization, Tableting and Coating establish AMS as a resource for lyophilization development and large scale manufacturing including tableting and enteric coating for...